FDA has approved biosimilar of Roche's Avastin

Amgen Inc. AMGN, -1.37% and Allergan AGN, -1.08% said Thursday that the Food and Drug Administration has approved their biosimilar version of Roche's Avastin for five types of cancer.09/15/2017
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news